KOREA WHO
-
-
Chairman of Jeil Pharma Holdings
Han Seung-soo
Second-Generation Owner of 'Patch Specialist' Jeil Pharmaceutical, Succeeds in Launching First New Drug
-
Last Updated on Oct 23, 2024
-
Chairman of Jeil Pharma Holdings
Copy Url : https://www.koreawho.com/profile/HanSeungsoo- Life Summary
Han Seung-soo is the chairman of Jeil Pharma Holdings.
He was born on November 10, 1947 (lunar calendar) in Seoul as the son of the late Han Won-seok, founder of Jeil Pharmaceutical.
Han graduated from Seoul High School and the business administration department at Oklahoma State University in the United States.
He joined Jeil Pharmaceutical in 1975 and has been serving as the chairman of Jeil Pharma Holdings since 2017.
Under his leadership, the company has expanded its business focus from products such as the “Penguin Patch” Jeilpaf and the arthritis patch treatment *Kepentech* to new drug development.
Han is currently concentrating efforts on listing Onconic Therapeutics, a specialized subsidiary for drug development, on the KOSDAQ market by 2024.
#HanSeungsoo #JeilPharmaHoldings #OnconicTherapeutics #JeilPharmaceutical #PenguinPatch #KOSDAQIPO #newdrugdevelopment #Kepentech #pharmaceuticals #businessleader
He was born on November 10, 1947 (lunar calendar) in Seoul as the son of the late Han Won-seok, founder of Jeil Pharmaceutical.
Han graduated from Seoul High School and the business administration department at Oklahoma State University in the United States.
He joined Jeil Pharmaceutical in 1975 and has been serving as the chairman of Jeil Pharma Holdings since 2017.
Under his leadership, the company has expanded its business focus from products such as the “Penguin Patch” Jeilpaf and the arthritis patch treatment *Kepentech* to new drug development.
Han is currently concentrating efforts on listing Onconic Therapeutics, a specialized subsidiary for drug development, on the KOSDAQ market by 2024.
#HanSeungsoo #JeilPharmaHoldings #OnconicTherapeutics #JeilPharmaceutical #PenguinPatch #KOSDAQIPO #newdrugdevelopment #Kepentech #pharmaceuticals #businessleader
- Life Summary
- Career Highlights & Challenges
- · Jeil Pharma Holdings' Governance Structure
- · Expanding Business Scope through New Drug Development, Shift to Losses
- · Onconic Therapeutics Advances KOSDAQ IPO Plans
- · Jeil Pharmaceutical Launches New GERD Drug ‘Zacubo Tab’
- · Novel Dual-Target Anti-Cancer Drug 'Nesuparib' Preclinical Study Results Announced
- · Jeil Pharmaceutical Signs Exclusive Supply Agreement with Malaysia’s National Medical University
- · Jeil Pharmaceutical’s Penguin Patch 'Jeilpaf' Now Available at Daiso
- · Jeil Pharmaceutical Secures Strong Position in Patch Market
- · Third-Generation Leadership Takes Hold
- · Jeil Pharmaceutical's Largest Shareholder Changes as It Becomes a Subsidiary of Jeil Pharma Holdings
- · Diversifying Business with Derma-Cosmetic Brand 'NISL'
- · Jeil Pharmaceutical, Jeil Health Science, and Jeil & Partners Structure Established
- · From Foundation to Present: History of Jeil Pharmaceutical
- · Milestones of Jeil Pharma Holdings
- Vision and Goals
- Market and Social Evaluation
- Notable Incidents & Legal Affairs
- Professional Timeline
- Educational Background
- Family & Personal Connections
- Awards & Recognitions
- Additional Information
- Notable Quotations
- Infographic & Photos